期刊文献+

辛伐他汀对冠心病患者血清脂联素水平的影响 被引量:1

下载PDF
导出
摘要 目的探讨辛伐他汀对冠心病患者血清脂联素水平的影响。方法选取被确诊的冠心病患者40例为治疗组,34例冠心病患者为对照组,治疗组给予辛伐他汀20 mg,每日1次,治疗8周,对照组不做给药处理。分别检查2组血清脂联素在治疗前后的水平。结果在治疗前2组血清脂联素水平相近,无显著性差异;在治疗后治疗组血清脂联素水平较对照组升高,有显著性差异。结论辛伐他汀在治疗冠心病患者时对提高血清脂联素水平有很好的疗效。
出处 《现代中西医结合杂志》 CAS 2013年第26期2879-2880,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献11

  • 1郁志明,洪侃,薛一峰,陆卫红,冯健.不同他汀类调脂药物对冠心病患者血清脂联素的影响[J].临床心血管病杂志,2008,24(9):651-652. 被引量:5
  • 2Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadi- ponectinemia with coronary artery disease in men [ J ]. Arterioscler Thromb Vasc Biol,2003,23 ( 1 ) :85 -89.
  • 3张蔚.他汀类药物治疗高脂血症的临床应用[J].新医学,2007,38(5):330-331. 被引量:22
  • 4Yokota T, Oritani K,Takahashi l,et al. Adiponectin,a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macropha: gesIJ]. Blood,2000,96(5):1723-1732.
  • 5Engeli S, Feldpausch M, Gorzelniak K, et al. Association betweenadiponectin and mediators of inflammation in obese women[ J ]. Di- abetes,2003,52(4) :942 - 947.
  • 6Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma pro- tein, adiponectin, suppresses lipid accumulation and class A scav- enger receptor expression in human monocyte-derived macrophages [ J ]. Criculation ,2001,103 (8) : 1057 - 1063.
  • 7Matsuda M ,Shimomura I,Sata M ,et al. Role of adiponectin in pre- venting vascular stenosis. The missing link of adiponectin vascular axis [ J ]. Siol Chem, 2002,277 ( 40 ) : 37484 - 37491.
  • 8Kubota N ,Terauchi Y,Yamauchi T, et al. Disruption of adiponectin causes in resistance and neointimal formation [ J ]. J Biol Chem, 2002,227 ( 29 ) :25863 - 25866.
  • 9Hashimoto M, Akita H. Cerivastatin, a hydroxy-methylglutaryl co- enzyme a reductase inhibitor,improves endothelial function in elder- ly diabetic patients within 3 days [ J ]. Circulation, 2002,105 ( 4 ) : E30 - E31.
  • 10Kadowaki T, Yamauehi T, Kubota N, et al. Adiponectin and adi- ponectin receptors in insulin resistance diabetes, and the metabolic syndrome[J]. J Clin Invest,2006,116(7):1784-1789.

二级参考文献19

  • 1吕瑞娟,张运,陈玉国,孙袆,王文君.他汀类药物治疗ALT升高的急性冠状动脉综合征的可行性研究[J].新医学,2006,37(6):368-369. 被引量:16
  • 2周陵,陈绍良,马玉玲,叶飞,林松,朱建成,单守杰,谢渡江.急性心肌梗死患者血清脂联素与C反应蛋白的关系[J].临床心血管病杂志,2006,22(6):376-377. 被引量:3
  • 3郁志明,杨志健,张笛,洪侃.降脂治疗对冠心病患者脂联素水平的影响[J].江苏医药,2006,32(9):887-887. 被引量:5
  • 4李靖,赵水平.脂联素与心血管疾病研究现状[J].临床心血管病杂志,2006,22(11):699-701. 被引量:8
  • 5HOTTA K, FUNAHASHI T, ARITA Y, et al. Plasma concentrations of a novel, adipose-spe- cificprotein, adiponectin, in type 2 diabetic patients [J].Arterioscler Thromb Vasc Biol, 2000, 20:1595 --1599.
  • 6YOKOTA T, ORITANI K, TAKAHASHI I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages[J]. Blood, 2000, 96: 1723--1732.
  • 7HASHIMOTO M, AKITA H. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days[J]. Circulation, 2002, 105: E30--E31.
  • 8TSIARA S, ELISAF M. Early vascular benefits of statin therapy[J]. Curr Med Res Opin, 2003, 19: 540--556.
  • 9陈汝筑,黄守坚,主编.治疗药理学[M].北京:人民卫生出版社,2003.173-176.
  • 10MOON Y S,KASHYAP M L.Niacin extended-release/lovastatin:combination therapy for lipid disorders[J].Expert Opin Pharmacother,2002,3(12):1763-1771.

共引文献25

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部